A phase 1 study in healthy volunteers exploring the safety, pharmacokinetics and pharmacodynamics of ati-450: A novel oral mk2 inhibitor

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2020
This article has no abstract
Epistemonikos ID: 06806d4e0592350e85570719b153654841ea58e3
First added on: Mar 24, 2022